GlassScriptPhysician profile
Alvin He
NPI 1073897559
$4,172.29
in general payments reported to CMS, 2019-2025
17 companies · $378 in 2025
The $378 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $752 · 2022: $1,193 · 2023: $1,166 · 2024: $683 · 2025: $378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,227.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,227.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,361.77 | 2021-2025 | |
| Gilead Sciences, INC. | $893.82 | 2021-2025 | Epclusa, Vemlidy |
| Esperion Therapeutics, INC. | $667.52 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $246.44 | 2022-2023 | Cyltezo |
| Pfizer INC. | $241.11 | 2023-2024 | |
| Angiodynamics, INC. | $135.48 | 2024 | Angiodynamics |
| Sirtex Medical INC | $134.49 | 2023 | Sir-Spheres Microspheres |
| Madrigal Pharmaceuticals | $127.89 | 2024-2025 | Rezdiffra, Resmetirom |
| Daiichi Sankyo INC. | $124.75 | 2023 | Injectafer |
| Advanced Respiratory, INC | $42.08 | 2021 | |
| Glaxosmithkline, LLC. | $38.76 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $38.03 | 2024 | Xifaxan |
| Vivus LLC | $31.39 | 2022 | |
| Aimmune Therapeutics, INC. | $27.76 | 2024 | |
| Celgene Corporation | $21.84 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $21.46 | 2023 | Dificid |
| Braintree Laboratories, INC. | $17.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alvin He listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.